drugset / Trial / NCT05683249
Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of NRCT-101SR compared to placebo in adult patients with ADHD aged 18 years and older.
Timeline
- Start
- 2023-02-25
- Primary completion
- 2024-01-17
- Completion
- 2024-01-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NRCT-101SR | Unknown | 1500 mg | Oral |
| Subject | NRCT-101SR | Unknown | 2000 mg | Oral |